The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Melatonin: an inhibitor of breast cancer
Open accessAbstract
The present review discusses recent work on melatonin-mediated circadian regulation, the metabolic and molecular signaling mechanisms that are involved in human breast cancer growth, and the associated consequences of circadian disruption by exposure to light at night (LEN). The anti-cancer actions of the circadian melatonin signal in human breast cancer cell lines and xenografts heavily involve MT 1 receptor-mediated mechanisms. In estrogen receptor alpha (ERα)-positive human breast cancer, melatonin suppresses ERα mRNA expression and ERα transcriptional activity via the MT 1 receptor. Melatonin also regulates the transactivation of other members of the nuclear receptor superfamily, estrogen-metabolizing enzymes, and the expression of core clock and clock-related genes. Furthermore, melatonin also suppresses tumor aerobic metabolism (the Warburg effect) and, subsequently, cell-signaling pathways critical to cell proliferation, cell survival, metastasis, and drug resistance. Melatonin demonstrates both cytostatic and cytotoxic activity in breast cancer cells that appears to be cell type-specific. Melatonin also possesses anti-invasive/anti-metastatic actions that involve multiple pathways, including inhibition of p38 MAPK and repression of epithelial–mesenchymal transition (EMT). Studies have demonstrated that melatonin promotes genomic stability by inhibiting the expression of LINE-1 retrotransposons. Finally, research in animal and human models has indicated that LEN-induced disruption of the circadian nocturnal melatonin signal promotes the growth, metabolism, and signaling of human breast cancer and drives breast tumors to endocrine and chemotherapeutic resistance. These data provide the strongest understanding and support of the mechanisms that underpin the epidemiologic demonstration of elevated breast cancer risk in night-shift workers and other individuals who are increasingly exposed to LEN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Phototransduction by retinal ganglion cells that set the circadian clock
Berson, D. M., Dunn, F. A., & Takao, M. (2002) · Science · doi:10.1126/science.1067262 · Cited by 3,629
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor
Brainard, G. C., Hanifin, J. P., Greeson, J. M., Byrne, B., Glickman, G., Gerner, E., & Rollag, M. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06405.2001 · Cited by 1,930
Weinberg, R. A., & Weinberg, R. A. (2006) · W.W. Norton eBooks · doi:10.1201/9780203852569 · Cited by 1,751
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
The Pineal and Its Hormones in the Control of Reproduction in Mammals*
REITER, R. J. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-2-109 · Cited by 1,250
A clockwork web: circadian timing in brain and periphery, in health and disease
Hastings, M. H., Reddy, A. B., & Maywood, E. S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1177 · Cited by 1,195
Rotating night shifts and risk of breast cancer in women participating in the nurses׳ health study
Schernhammer, E. S., Laden, F., Speizer, F. E., Willett, W. C., Hunter, D. J., Kawachi, I., & Colditz, G. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1563 · Cited by 1,142
Carcinogenicity of shift-work, painting, and fire-fighting
Straif, K., Baan, R., Grosse, Y., Secretan, B., Ghissassi, F. E., Bouvard, V., Altieri, A., Benbrahim-Tallaa, L., & Cogliano, V. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70373-x · Cited by 1,082
Extrapineal melatonin: sources, regulation, and potential functions
Acuña-Castroviejo, D., Escames, G., Venegas, C., Díaz-Casado, M. E., Lima-Cabello, E., López, L. C., Rosales-Corral, S., Tan, D.-X., & Reiter, R. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1579-2 · Cited by 1,076
Hot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073
The basic physiology and pathophysiology of melatonin
Claustrat, B., Brun, J., & Chazot, G. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.08.001 · Cited by 950
Night Shift Work, Light at Night, and Risk of Breast Cancer
Davis, S., Mirick, D. K., & Stevens, R. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1557 · Cited by 930
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Tensegrity II. How structural networks influence cellular information processing networks
Ingber, D. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00360 · Cited by 839
HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 803
Melatonin membrane receptors in peripheral tissues: Distribution and functions
Slominski, R. M., Reiter, R. J., Schlabritz-Loutsevitch, N., Ostrom, R. S., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.004 · Cited by 675
Melatonin: The chemical expression of darkness
Reiter, R. J. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90087-9 · Cited by 632
Dubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 621
Single-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain
Evrony, G. D., Cai, X., Lee, E., Hills, L. B., Elhosary, P. C., Lehmann, H. S., Parker, J. J., Atabay, K. D., Gilmore, E. C., Poduri, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.035 · Cited by 548 · cited 2×
“07 de novo inserts per normal cell (neuron) (Evrony et al. 2012).”
BackgroundInfluentialJournal of Biological Regulators and Homeostatic Agents
Bolognesi, A. (2006) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 548
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
Robey, R. B., & Hay, N. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.010 · Cited by 540
Melatonin, hydroxyl radical‐mediated oxidative damage, and aging: A hypothesis
Poeggeler, B., Reiter, R. J., Tan, D., Chen, L., & Manchester, L. C. (1993) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1993.tb00498.x · Cited by 501
ELECTRIC POWER USE AND BREAST CANCER: A HYPOTHESIS
STEVENS, R. G. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114569 · Cited by 499
Wnt Signaling Mediates Self-Organization and Axis Formation in Embryoid Bodies
ten Berge, D., Koole, W., Fuerer, C., Fish, M., Eroglu, E., & Nusse, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.013 · Cited by 477
Molecular pharmacology regulation and function of mammalian melatonin receptors
Dubocovich, M. L. (2003) · Frontiers in Bioscience · doi:10.2741/1089 · Cited by 451
Melatonin, sleep disturbance and cancer risk
Blask, D. E. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.07.007 · Cited by 449
Self-citationOvercoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
Burris, H. A. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2043-3 · Cited by 440
Hill, S. M., & Blask, D. E. (1988) · PubMed · Cited by 437
Self-citationPineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily.
Becker-André, M., Wiesenberg, I., Schaeren-Wiemers, N., André, E., Missbach, M., Saurat, J. H., & Carlberg, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61934-4 · Cited by 434
Blask, D. E., Brainard, G. C., Dauchy, R. T., Hanifin, J. P., Davidson, L. K., Krause, J. A., Sauer, L. A., Rivera-Bermudez, M. A., Dubocovich, M. L., Jasser, S. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1945 · Cited by 432
Self-citationIsolation of Melatonin and 5-Methoxyindole-3-acetic Acid from Bovine Pineal Glands
Lerner, A. B., Case, J. D., & Takahashi, Y. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69351-2 · Cited by 416
The Regulation of Intracellular Calcium
Carafoli, E., & Crompton, M. (1978) · Current Topics in Membranes and Transport · doi:10.1016/s0070-2161(08)60835-7 · Cited by 409
Regulation and function of the RSK family of protein kinases
Romeo, Y., Zhang, X., & Roux, P. P. (2012) · Biochemical Journal · doi:10.1042/bj20110289 · Cited by 377
Stevens, R. G., Blask, D. E., Brainard, G. C., Hansen, J., Lockley, S. W., Provencio, I., Rea, M. S., & Reinlib, L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10200 · Cited by 358
Self-citationLevoye, A., Dam, J., Ayoub, M. A., Guillaume, J., Couturier, C., Delagrange, P., & Jockers, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601193 · Cited by 334
Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., & Jockers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200729200 · Cited by 322
Epithelial to mesenchymal transition and breast cancer
Tomaskovic-Crook, E., Thompson, E. W., & Thiery, J. P. (2009) · Breast Cancer Research · doi:10.1186/bcr2416 · Cited by 318
Huether, G. (1993) · Experientia · doi:10.1007/bf01923948 · Cited by 304
Melatonin receptors and their regulation: biochemical and structural mechanisms
Witt-Enderby, P. A., Bennett, J., Jarzynka, M. J., Firestine, S., & Melan, M. A. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00098-5 · Cited by 302
Transactivation of Vimentin by Beta-Catenin in Human Breast Cancer Cells
Gilles, C., Polette, M., Mestdagt, M., Nawrocki-Raby, B., Ruggeri, P., Birembaut, P., & Foidart, J.-M. (2003) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200303001-00219 · Cited by 301
Tamarkin, L., Cohen, M., Roselle, D., Reichert, C. M., Lippman, M. E., & Chabner, B. A. (1981) · PubMed · Cited by 296
Expression profiling of epithelial plasticity in tumor progression
Jechlinger, M., Grunert, S., Tamir, I. H., Janda, E., Lüdemann, S., Waerner, T., Seither, P., Weith, A., Beug, H., & Kraut, N. (2003) · Oncogene · doi:10.1038/sj.onc.1206887 · Cited by 294
Melatonin and pregnancy in the human
Tamura, H., Nakamura, Y., Terron, M. P., Flores, L. J., Manchester, L. C., Tan, D.-X., Sugino, N., & Reiter, R. J. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.03.005 · Cited by 293
Dual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 Proteins
Brydon, L. (1999) · Molecular Endocrinology · doi:10.1210/me.13.12.2025 · Cited by 281
Circadian molecular clocks and cancer
Kelleher, F. C., Rao, A., & Maguire, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.09.040 · Cited by 276
Lissoni, P., Barni, S., Mandalà, M., Ardizzoia, A., Paolorossi, F., Vaghi, M., Longarini, R., Malugani, F., & Tancini, G. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00159-8 · Cited by 253
über den Stoffwechsel der Carcinomzelle
Warburg, O. (1925) · Klinische Wochenschrift · doi:10.1007/bf01726151 · Cited by 253
Cytoplasmic microtubules and their functions
Roberts, K. (1974) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(74)90022-4 · Cited by 250
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos, S., Fernández, R., Güezmes, A., & Sánchez‐Barceló, E. J. (1998) · PubMed · Cited by 246
Direct Action of Melatonin in Human Granulosa-Luteal Cells
Woo, M. M. M., Tai, C.-J., Kang, S. K., Nathwani, P. S., Pang, S. F., & Leung, P. C. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4789 · Cited by 240
Light at Night, Chronodisruption, Melatonin Suppression, and Cancer Risk: A Review
Reiter, R. J., Tan, D.-X., Korkmaz, A., Erren, T. C., Piekarski, C., Tamura, H., & Manchester, L. C. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i4.30 · Cited by 236
A sense of time: how molecular clocks organize metabolism
Kohsaka, A., & Bass, J. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.11.005 · Cited by 234
Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
D. Mediavilla, M., J. Sanchez-Barcelo, E., X. Tan, D., Manchester, L., & J. Reiter, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710794183015 · Cited by 234
CEP152 is a genome maintenance protein disrupted in Seckel syndrome
Kalay, E., Yigit, G., Aslan, Y., Brown, K. E., Pohl, E., Bicknell, L. S., Kayserili, H., Li, Y., Tüysüz, B., Nürnberg, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.725 · Cited by 229
Melatonin–estrogen interactions in breast cancer
Sánchez‐Barceló, E. J., Cos, S., Mediavilla, D., Martínez‐Campa, C., González, A., & Alonso‐González, C. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00207.x · Cited by 228
Reversible DNA methylation regulates seasonal photoperiodic time measurement
Stevenson, T. J., & Prendergast, B. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310643110 · Cited by 221
The clock gene Per2 links the circadian system to the estrogen receptor
Gery, S., Virk, R. K., Chumakov, K., Yu, A., & Koeffler, H. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210585 · Cited by 218
Transactivation of vimentin by beta-catenin in human breast cancer cells.
Gilles, C., Polette, M., Mestdagt, M., et al. (2003) · PubMed · Cited by 210
Locasale, J. W., & Cantley, L. C. (2010) · BMC Biology · doi:10.1186/1741-7007-8-88 · Cited by 198
Blask, D. E., Sauer, L. A., Dauchy, R. T., Holowachuk, E. W., Ruhoff, M. S., & Kopff, H. S. (1999) · PubMed · Cited by 198
Self-citationMelatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitro
Mediavilla, M. D., Cos, S., & Sánchez-Barceló, E. J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00262-3 · Cited by 190
All y’all need to know ‘bout retroelements in cancer
Belancio, V. P., Roy-Engel, A. M., & Deininger, P. L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.06.001 · Cited by 188
Self-citationBlask, D. E., Hill, S. M., Dauchy, R. T., Xiang, S., Yuan, L., Duplessis, T., Mao, L., Dauchy, E., & Sauer, L. A. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00888.x · Cited by 187
Self-citationMelatonin and Mammary Pathological Growth
Cos, S., & Sánchez-Barceló, E. J. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0194 · Cited by 186
Melatonin: A Clock‐Output, A Clock‐Input
Stehle, J. H., Von Gall, C., & Korf, H. ‐. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01001.x · Cited by 181
Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver
Kassner, N., Huse, K., Martin, H.-J., Gödtel-Armbrust, U., Metzger, A., Meineke, I., Brockmöller, J., Klein, K., Zanger, U. M., Maser, E., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022251 · Cited by 180
Melatonin, an Endogenous-specific Inhibitor of Estrogen Receptor α via Calmodulin
del Río, B., Garcia-Pedrero, J. M., Martínez‐Campa, C., Zuazua, P., Lazo, P. S., & Ramos, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403140200 · Cited by 169
Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells
Molis, T. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.12.1681 · Cited by 168
Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate
Hsi, L. C., Wilson, L. C., & Eling, T. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203522200 · Cited by 165
Diurnal rhythm of free estradiol during the menstrual cycle
Bao, A., Liu, R., van Someren, E., Hofman, M., Cao, Y., & Zhou, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480227 · Cited by 165
Human phase response curve to a single 6.5 h pulse of short‐wavelength light
Rüger, M., St Hilaire, M. A., Brainard, G. C., Khalsa, S. S., Kronauer, R. E., Czeisler, C. A., & Lockley, S. W. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239046 · Cited by 161
Dauchy, R. T., Xiang, S., Mao, L., Brimer, S., Wren, M. A., Yuan, L., Anbalagan, M., Hauch, A., Frasch, T., Rowan, B. G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3156 · Cited by 161
Self-citationMelatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro
Leon-Blanco, M. M., Guerrero, J. M., Reiter, R. J., Calvo, J. R., & Pozo, D. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00077.x · Cited by 161
Mao, L., Yuan, L., Slakey, L. M., Jones, F. E., Burow, M. E., & Hill, S. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2794 · Cited by 160
Self-citationMolecular pathways involved in seasonal body weight and reproductive responses governed by melatonin
Barrett, P., & Bolborea, M. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00963.x · Cited by 158
Cos, S., Blask, D. E., Lemus-Wilson, A. M., & Hill, A. B. (1991) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1991.tb00007.x · Cited by 155
Self-citationInvolvement of the mt1 melatonin receptor in human breast cancer
Ram, P. T., Dai, J., Yuan, L., Dong, C., Kiefer, T. L., Lai, L., & Hill, S. M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00873-4 · Cited by 154
Self-citationChen, A., Beetham, H. G., Black, M. A., Priya, R., Telford, B. J., Guest, J., Wiggins, G. A. R., Godwin, T. D., Yap, A. S., & Guilford, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-552 · Cited by 152
Lissoni, P., Barni, S., Meregalli, S., Fossati, V., Cazzaniga, M. E., Esposti, D., & Tancini, G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.164 · Cited by 150
Yuan, L., Collins, A., Dai, J., Dubocovich, M. L., & Hill, S. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00029-1 · Cited by 147
Self-citationLiu, R., Fu, A., Hoffman, A. E., Zheng, T., & Zhu, Y. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-1 · Cited by 147
Hollestelle, A., Peeters, J. K., Smid, M., Timmermans, M. A. M., Verhoog, L. C., Westenend, P. J., Heine, A. A. J., Chan, A. B., Sieuwerts, A. M., Wiemer, E. A. C., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2415-3 · Cited by 141
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
Grant, S. G., Melan, M. A., Latimer, J. J., & Witt‐Enderby, P. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000982 · Cited by 141
Blask, D. E., Dauchy, R. T., Dauchy, E. M., Mao, L., Hill, S. M., Greene, M. W., Belancio, V. P., Sauer, L. A., & Davidson, L. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102776 · Cited by 141
Self-citationHill, S. M., Spriggs, L. L., Simon, M. A., Muraoka, H., & Blask, D. E. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90050-6 · Cited by 138
Self-citationNF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen
deGraffenried, L. A., Chandrasekar, B., Friedrichs, W. E., Donzis, E. J., Silva-Fisher, J., Hidalgo, M. M., Freeman, J. W., & Weiss, G. R. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh232 · Cited by 136
Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells
Kiefer, T. L., Ram, P. T., Yuan, L., & Hill, S. M. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1013301408464 · Cited by 125
Self-citationCarrillo‐Vico, A., García‐Mauriño, S., Calvo, J. R., & Guerrero, J. M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0501fje · Cited by 123
Sims, J. T., Ganguly, S. S., Bennett, H., Friend, J. W., Tepe, J., & Plattner, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055509 · Cited by 121
Light‐Induced Melatonin Suppression in Humans with Polychromatic and Monochromatic Light
Revell, V. L., & Skene, D. J. (2007) · Chronobiology International · doi:10.1080/07420520701800652 · Cited by 115
Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines
Fan, L., Sun, G., Wei, W., Wang, Z., Ge, L., Fu, W.-Z., & Wang, H. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1473 · Cited by 112
Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer
Hill, S. M., Blask, D. E., Xiang, S., Yuan, L., Mao, L., Dauchy, R. T., Dauchy, E. M., Frasch, T., & Duplessis, T. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9222-4 · Cited by 106
Self-citationLee, S. E., Kim, S. J., Youn, J.-P., Hwang, S. Y., Park, C., & Park, Y. S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00896.x · Cited by 106
Breast cancer risk, nightwork, and circadian clock gene polymorphisms
Truong, T., Liquet, B., Menegaux, F., Plancoulaine, S., Laurent‐Puig, P., Mulot, C., Cordina‐Duverger, E., Sanchez, M., Arveux, P., Kerbrat, P., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0121 · Cited by 104
Xiang, S., Dauchy, R. T., Hauch, A. T., Mao, L., Yuan, L., Wren, M. A., Belancio, V. P., Mondal, D., Frasch, T., Blask, D. E., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12239 · Cited by 103
Self-citationEvidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells
Cucina, A., Proietti, S., D’Anselmi, F., Coluccia, P., Dinicola, S., Frati, L., & Bizzarri, M. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00645.x · Cited by 101
Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF ‐7 cells
Proietti, S., Cucina, A., Dobrowolny, G., D’Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12150 · Cited by 100
Proietti, S., Cucina, A., D’Anselmi, F., Dinicola, S., Pasqualato, A., Lisi, E., & Bizzarri, M. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00824.x · Cited by 99
Bracke, M. E., Larebeke, N. V., Vyncke, B. M., & Mareel, M. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.191 · Cited by 96
Lee, S. A., Karaszkiewicz, J. W., & Anderson, W. B. (1992) · PubMed · Cited by 95
Daily coordination of cancer growth and circadian clock gene expression
You, S., Wood, P. A., Xiong, Y., Kobayashi, M., Du‐Quiton, J., & Hrushesky, W. J. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-6603-z · Cited by 91
Mao, L., Dauchy, R. T., Blask, D. E., Slakey, L. M., Xiang, S., Yuan, L., Dauchy, E. M., Shan, B., Brainard, G. C., Hanifin, J. P., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1071 · Cited by 91
Self-citationWood, P. A., Yang, X., & Hrushesky, W. J. M. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409355292 · Cited by 91
Martínez‐Campa, C., González, A., Mediavilla, M. D., Alonso‐González, C., Garcia, V. A., Sánchez‐Barceló, E. J., & Cos, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605336 · Cited by 90
Li, Q., Mullins, S., Sloane, B. F., & Mattingly, R. R. (2008) · Neoplasia · doi:10.1593/neo.07970 · Cited by 87
García, J. J., Reiter, R. J., Ortíz, G. G., Oh, C. S., Tang, L., & B.P. Yu *, †. (1998) · The Journal of Membrane Biology · doi:10.1007/s002329900342 · Cited by 87
Blask, D. E., Wilson, S. T., & Zalatan, F. (1997) · PubMed · Cited by 85
Self-citationMolecular mechanisms of melatonin’s inhibitory actions on breast cancers
Proietti, S., Cucina, A., Reiter, R. J., & Bizzarri, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1161-8 · Cited by 84
The role of polymorphisms in circadian pathway genes in breast tumorigenesis
Dai, H., Zhang, L., Cao, M., Song, F., Zheng, H., Zhu, X., Wei, Q., Zhang, W., & Chen, K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1231-2 · Cited by 81
Eck, K., Yuan, L., Duffy, L., Ram, P. T., Ayettey, S., Chen, I., Cohn, C., Reed, J., & Hill, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.357 · Cited by 81
Self-citationInactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
Novotná, R., Wsól, V., Xiong, G., & Maser, E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.06.858 · Cited by 80
Collins, A., Yuan, L., Kiefer, T. L., Cheng, Q., Lai, L., & Hill, S. M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00502-5 · Cited by 80
Self-citationModulation of intracellular calcium and calmodulin by melatonin in MCF‐7 human breast cancer cells
Dai, J., Inscho, E. W., Yuan, L., & Hill, S. M. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.1844.x · Cited by 79
Self-citationEl‐Aziz, M. A. A., Hassan, H., Mohamed, M. H., et al. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00448.x · Cited by 79
Lazennec, G., Thomas, J. A., & Katzenellenbogen, B. S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00060-7 · Cited by 77
Deane, J. A., & Hickey, M. J. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900115x · Cited by 77
Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)
Lewis-Wambi, J. S., & Jordan, V. C. (2006) · Breast Disease · doi:10.3233/bd-2006-24108 · Cited by 75
Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro
Wilson, S. T., Blask, D. E., & Lemus-Wilson, A. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639964 · Cited by 74
Self-citationExpression of melatonin receptor MT 1 in cells of human invasive ductal breast carcinoma
Jabłońska, K., Puła, B., Zemła, A., Owczarek, T. B., Wojnar, A., Ryś, J., Ambicka, A., Podhorska‐Okołów, M., Ugorski, M., & Dzięgiel, P. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12032 · Cited by 72
Wu, J., Dauchy, R. T., Tirrell, P. C., Wu, S. S., Lynch, D. T., Jitawatanarat, P., Burrington, C. M., Dauchy, E. M., Blask, D. E., & Greene, M. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3837 · Cited by 71
Self-citationSignificance of ER–Src axis in hormonal therapy resistance
Vallabhaneni, S., Nair, B. C., Cortez, V. A., Challa, R., Chakravarty, D., TEKMAL, R. R., & Vadlamudi, R. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1312-2 · Cited by 68
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Santoro, R., Mori, F., Marani, M., Grasso, G., Cambria, M. A., Blandino, G., Muti, P. C., & Strano, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt025 · Cited by 68
Xiang, S., Mao, L., Duplessis, T., Yuan, L., Dauchy, R. T., Dauchy, E., Blask, D. E., Frasch, T., & Hill, S. M. (2012) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s9673 · Cited by 67
Self-citationTranscriptional repression of RORα activity in human breast cancer cells by melatonin
Dai, J., Ram, P. T., Yuan, L., Spriggs, L. L., & Hill, S. M. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00449-x · Cited by 65
Self-citationLight During Darkness and Cancer: Relationships in Circadian Photoreception and Tumor Biology
Jasser, S. A., Blask, D. E., & Brainard, G. C. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-9013-6 · Cited by 65
Self-citationGlasgow, W. C., Hui, R., Everhart, A. L., Jayawickreme, S. P., Angerman‐Stewart, J., Han, B., & Eling, T. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19269 · Cited by 64
Anbalagan, M., Carrier, L., Glodowski, S., Hangauer, D. G., Shan, B., & Rowan, B. G. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1513-3 · Cited by 62
Lee, S. E., Kim, S. J., Yoon, H., Yu, S. Y., Yang, H., Jeong, S. I., Hwang, S. Y., Park, C., & Park, Y. S. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01027.x · Cited by 62
ESR1 and ESR2 Differentially Regulate Daily and Circadian Activity Rhythms in Female Mice
Royston, S. E., Yasui, N., Kondilis, A., Lord, S., Katzenellenbogen, J. A., & Mahoney, M. M. (2014) · Endocrinology · doi:10.1210/en.2014-1101 · Cited by 61
Clocks Underneath: The Role of Peripheral Clocks in the Timing of Female Reproductive Physiology
Sellix, M. T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00091 · Cited by 60
Sauer, L. A., Dauchy, R. T., Blask, D. E., Armstrong, B. J., & Scalici, S. (1999) · PubMed · Cited by 60
Self-citationdeHaro, D. L., Kines, K. J., Sokolowski, M. J., Dauchy, R. T., Streva, V. A., Hill, S. M., Hanifin, J. P., Brainard, G. C., Blask, D. E., & Belancio, V. P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku503 · Cited by 60
Self-citationKiefer, T. L., Lai, L., Yuan, L., Dong, C., Burow, M. E., & Hill, S. M. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00198.x · Cited by 57
Self-citationDicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells
Selever, J., Gu, G., Lewis, M. T., Beyer, A. R., Herynk, M. H., Covington, K. R., Tsimelzon, A. I., Dontu, G., Provost, P., Pietro, A. D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1403 · Cited by 55
The aging clock and circadian control of metabolism and genome stability
Belancio, V. P., Blask, D. E., Deininger, P. L., Hill, S. M., & Jazwinski, S. M. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2014.00455 · Cited by 55
Self-citationSteffens, F., Zhou, X., Sausbier, U., Sailer, C. A., Motejlek, K., Ruth, P., Olcese, J., Korth, M., & Wieland, T. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0047 · Cited by 53
Oprea‐Ilies, G., Haus, E. L., Sackett-Lundeen, L. L., Liu, Y., McLendon, L., Busch, R. S., Adams, A. L., & Cohen, C. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2371-3 · Cited by 51
Lai, L., Yuan, L., Cheng, Q., Dong, C., Mao, L., & Hill, S. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0220-1 · Cited by 49
Self-citationAustreid, E., Lønning, P. E., & Eikesdal, H. P. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.885952 · Cited by 49
Promiscuous drugs as therapeutics for chemokine receptors
Horuk, R. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000921 · Cited by 48
HUA, G., Liu, Y., Li, X., Xu, P., & Luo, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3156 · Cited by 47
González, A., Martínez‐Campa, C., Mediavilla, M., Alonso‐González, C., Sánchez-Mateos, S., Hill, S. M., Sánchez‐Barceló, E. J., & Cos, S. (2007) · Oncology Reports · doi:10.3892/or.17.4.947 · Cited by 45
Self-citationROCK Inhibition Activates MCF-7 Cells
Yang, S., & Kim, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088489 · Cited by 43
Oncostatic action of melatonin: facts and question marks.
Pawlikowski, M., Winczyk, K., & Karasek, M. (2002) · PubMed · Cited by 41
Lai, L., Yuan, L., Chen, Q., Dong, C., Mao, L., Rowan, B. G., Frasch, T., & Hill, S. M. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00620.x · Cited by 38
Self-citationTeplitzky, S., Kiefer, T. L., Cheng, Q., Dwivedi, P. D., Moroz, K., Myers, L., Anderson, M., Collins, A., Dai, J., Yuan, L., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00548-1 · Cited by 35
Self-citationSchuster, C., Williams, L. M., Morris, A., Morgan, P. J., & Barrett, P. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01288.x · Cited by 34
Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens
Rögelsperger, O., Ekmekçioğlu, C., Jäger, W. R., Klimpfinger, M., Königsberg, R., Krenbek, D., Sellner, F., & Thalhammer, T. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00679.x · Cited by 31
Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs
Bessone, M. I. D., Berardi, D. E., Campodónico, P. B., Todaro, L. B., Lothstein, L., Joffé, E. B. D. K., & Urtreger, A. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0956-2 · Cited by 30
Moriya, T., Hiraishi, K., Horie, N., Mitome, M., & Shinohara, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.018 · Cited by 29
Glasgow, W. C., & Eling, T. E. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1239 · Cited by 29
Impact of melatonin receptors on pCREB and clock-gene protein levels in the murine retina
Dinet, V., & Korf, H. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0468-5 · Cited by 28
Sauer, L. A., Dauchy, R. T., & Blask, D. E. (1997) · Journal of Nutrition · doi:10.1093/jn/127.7.1412 · Cited by 28
Self-citationDong, C., Yuan, L., Dai, J., Lai, L., Mao, L., Xiang, S., Rowan, B. G., & Hill, S. M. (2010) · Steroids · doi:10.1016/j.steroids.2010.06.002 · Cited by 27
Self-citationMao, L., Yuan, L., Xiang, S., Zeringue, S. B., Dauchy, R. T., Blask, D. E., Hauch, A. T., & Hill, S. M. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12117 · Cited by 27
Self-citationRegression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid
Mélançon, K., Cheng, Q., Kiefer, T. L., Dai, J., Lai, L., Dong, C., Yuan, L., Collins, A., Thiyagarajah, A., Long, S., et al. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.005 · Cited by 23
Self-citationUnderstanding Resistance to Endocrine Agents: Molecular Mechanisms and Potential for Intervention
Sabnis, G. J., & Brodie, A. M. H. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.014 · Cited by 23
Bondi, C., Alonso‐González, C., Clafshenkel, W. P., Kotlarczyk, M. P., Dodda, B. R., Sánchez‐Barceló, E. J., Davis, V. L., & Witt‐Enderby, P. A. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.027 · Cited by 20
Dauchy, R. T., Dauchy, E. M., Sauer, L. A., Blask, D. E., Davidson, L. K., Krause, J. A., & Lynch, D. T. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.012 · Cited by 19
Self-citationPer2 Is a C/EBP Target Gene Implicated in Myeloid Leukemia
Gery, S., & Koeffler, H. P. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409352084 · Cited by 16
Yon, V., & Loas, G. (2000) · Psychopathology · doi:10.1159/000029130 · Cited by 13
Yuan, J., Shi, G.-X., Shao, Y., Dai, G., Wei, J.-N., Chang, D. C., & Li, C. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.004 · Cited by 10
Michel, S. H., Block, G. D., & Meijer, J. H. (2015) · Wiley eBooks · doi:10.1002/9781118467831.ch22 · Cited by 3
Pintor, J. J. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60092-3 · Cited by 2
Cited by
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Melatonin Synthesis and Function: Evolutionary History in Animals and Plants
Zhao, D., Yu, Y., Shen, Y., Liu, Q., Zhao, Z., Sharma, R., & Reiter, R. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00249 · Cited by 689
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Rodgers, K. M., Udesky, J. O., Rudel, R. A., & Brody, J. G. (2018) · Environmental Research · doi:10.1016/j.envres.2017.08.045 · Cited by 443
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 433
Metadata
- Authors
- Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A., Lundberg, P. W., Summers, W., Yuan, L., Frasch, T., & Blask, D. E.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2015-04-15
- Volume
- 22
- Issue
- 3
- Pages
- R183-R204
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2090740247
- Cited by
- 317
- References
- 173
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.